Keita Fukao

Combination treatment with the cap-dependent endonuclease inhibitor baloxavir marboxil and a neuraminidase inhibitor in a mouse model of influenza A virus infection

Keita Fukao, Takeshi Noshi, Atsuko Yamamoto et al. · Journal of Antimicrobial Chemotherapy · 2018 · 97 citations · Full text

Expression of the chicken peroxisome proliferator-activated receptor-γ gene is influenced by aging, nutrition, and agonist administration

Kei Sato, Keita Fukao, Yoshinori Seki et al. · Poultry Science · 2004 · 63 citations · Full text

Baloxavir marboxil, a novel cap-dependent endonuclease inhibitor potently suppresses influenza virus replication and represents therapeutic effects in both immunocompetent and immunocompromised mouse models

Keita Fukao, Yoshinori Ando, Takeshi Noshi et al. · PLoS ONE · 2019 · 47 citations · Full text

Vaccination, Allergy, Virus Titer +11

Efficacy comparison of 3CL protease inhibitors ensitrelvir and nirmatrelvir against SARS-CoV-2<i>in vitro</i>and<i>in vivo</i>

Takayuki Kuroda, Haruaki Nobori, Keita Fukao et al. · Journal of Antimicrobial Chemotherapy · 2023 · 40 citations · Full text

Efficacy of ensitrelvir against SARS-CoV-2 in a delayed-treatment mouse model

Haruaki Nobori, Keita Fukao, Takayuki Kuroda et al. · Journal of Antimicrobial Chemotherapy · 2022 · 32 citations · Full text